Molecular mycological diagnosis and correct antimycotic treatments

about

Molecular diagnosis of polymicrobial sepsis.

P2860

Q43146546-B5ACE18E-03A9-40F8-BD7C-EDD03FDB644E

P2860

Molecular mycological diagnosis and correct antimycotic treatments

Item

http://www.wikidata.org/entity/Q42593284

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Molecular mycological diagnosis and correct antimycotic treatments

@en

Molecular mycological diagnosis and correct antimycotic treatments

@nl

type

Item

label

Molecular mycological diagnosis and correct antimycotic treatments

@en

Molecular mycological diagnosis and correct antimycotic treatments

@nl

prefLabel

Molecular mycological diagnosis and correct antimycotic treatments

@en

Molecular mycological diagnosis and correct antimycotic treatments

@nl

P1476

Molecular mycological diagnosis and correct antimycotic treatments

@en

P2093

Annette W Fothergill

http://www.w3.org/2001/XMLSchema#string

Cristina M Ossi

http://www.w3.org/2001/XMLSchema#string

Daniel B DiGiulio

http://www.w3.org/2001/XMLSchema#string

Gerald J Berry

http://www.w3.org/2001/XMLSchema#string

Joanna M Schaenman

http://www.w3.org/2001/XMLSchema#string

Jose G Montoya

http://www.w3.org/2001/XMLSchema#string

Laurence F Mirels

http://www.w3.org/2001/XMLSchema#string

Mario Perotti

http://www.w3.org/2001/XMLSchema#string

Michael G Rinaldi

http://www.w3.org/2001/XMLSchema#string

Nancy B McClenny

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi

Scedosporium apiospermum soft tissue infection successfully treated with voriconazole: potential pitfalls in the transition from intravenous to oral therapy.

History of the development of azole derivatives.

Validation of assembled nucleic acid-based tests in diagnostic microbiology laboratories.

Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.

Contaminations occurring in fungal PCR assays

In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates

Introducing a molecular test into the clinical microbiology laboratory: development, evaluation, and validation.

Rapid identification of fungi by sequencing the ITS1 and ITS2 regions using an automated capillary electrophoresis system.

Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum.

P304

3584; author reply 3584-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.43.7.3584-3585.2005

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Massimo Clementi

Nicasio Mancini

P577

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7742856

http://www.w3.org/2001/XMLSchema#string

P698

16000516

http://www.w3.org/2001/XMLSchema#string

P932

1169111

http://www.w3.org/2001/XMLSchema#string

Molecular mycological diagnosis and correct antimycotic treatments

about

P2860

P2860

Molecular mycological diagnosis and correct antimycotic treatments

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932